Download Files:
Products Details
Product Description
– TLR4/NF-κB/MAPK-IN-1 is a new type of antineuroinflammatory agent by suppressing TLR4/NF-kB/MAPK pathways.
Web ID
– HY-142963
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C19H25BrO6
References
– [1]Tang JJ, et al. 1,10-Seco-Eudesmane sesquiterpenoids as a new type of anti-neuroinflammatory agents by suppressing TLR4/NF-κB/MAPK pathways. Eur J Med Chem. 2021 Nov 15;224:113713.
CAS Number
– 2767567-26-8
Molecular Weight
– 429.30
SMILES
– C=C1C(O[C@@H]2CC(CBr)=C([C@H]([C@H]12)OC(C)=O)[C@H](CCCOC(C)=O)C)=O
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– NF-κB;p38 MAPK;Toll-like Receptor (TLR)
Pathway
– Immunology/Inflammation;MAPK/ERK Pathway;NF-κB
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
